Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Susanne M Arnold, MD
Lucille P. Markey Cancer Center at University of Kentucky
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Treatment Centers of America, Western Regional Medical Center
Goodyear, Arizona, United States
- University of Kentucky Markey Cancer Center
Lexington, Kentucky, United States
- Norton Cancer Institute
Louisville, Kentucky, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Providence Portland Medical Center | Earle A. Chiles Research Institute
Portland, Oregon, United States
- University of Texas Medical Branch at Galveston
Galveston, Texas, United States
- Virginia Mason Cancer Institute
Seattle, Washington, United States
- Aurora Research Institute | Aurora Cancer Care
Wauwatosa, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2013
- Primary completion
- 31 Dec 2018
- Completion
- 1 Jul 2019
- Last update posted
- 9 May 2024
- Registered enrollment
- 78
- Registry id
- NCT01941316
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.